Abstract
The modern medical
science has been greatly advanced by the development of new drugs, despite the
fact that the process of developing new drugs is costly and time-consuming. An
accurate prediction method for the drug-likeness at the early stage of drug discovery
is highly desirable, as it will facilitate the discovery process and reduce the
overall cost, and eventually contribute to the well-being of human beings.
Based on a central nervous system (CNS) drug dataset, we constructed an
artificial neural network (NN) to predict the CNS drug-likeness of a given
compound. Based on the published results, we first constructed a simple
feed-forward neural network to learn and predict the possible correlations
between twelve physiochemical properties and the CNS drug-likeness. The
accuracy of prediction has reached 80%, which is higher than previous reports.
The successful implementation of NN to predict the CNS drug-likeness indicated
that NN could be a powerful tool for the prediction. Moreover, we further
constructed a neural network based on the chemical structure, and the accuracy has
reached 86%. We hope that these methods can serve as an applicable set of
protocols for virtual drug screening.